The global direct to consumer microbiome analyzing market is growing efficiently, expected to grow at a CAGR of 11.8%. Globally, growing prevalence of chronic diseases along with gut infections has significantly increased the revenue of microbiome testing kits. New product launches along with raised funding for genome testing, and promising pipeline microbiome analyzing products in the DNA testing industry are factors driving the overall growth of direct to consumer microbiome analyzing market globally.
The thyroid function test market is set to reach US$ 2,203.7 Mn by 2027 from US$ 1,317.8 Mn in 2018 projecting impressive growth at a compounded annual growth rate (CAGR) of 5.9% during the forecast period from 2018 to 2026. The major risk factors associated with thyroid disorders are intake of iodine replete diet, hormonal imbalance, sedentary lifestyle and increasing consumption of alcohol and tobacco. Increasing public health awareness and technological advancement in diagnostic kits together drive the thyroid function tests market growth.
The global hematology diagnostics market is Increasing blood donation procedures, rising incidences of blood disorders along with enhanced diagnostics and hematology testing technologies drives the overall hematology diagnostics market growth. New technological evolution in automated hemotology analyzers would also drive the overall market.
The global audiological devices market accounted for US$ 11,574.1 Mn in 2021 and is anticipated to grow to US$ 18,649.0 Mn growing at a CAGR of 5.5% throughout the forecast period from 2025 to 2033. In 2021, in terms of volume market register sales of 18.50 Mn units and is anticipated to reach 30.38 Mn Units expanding at a CAGR of 5.7%.
The microplates market is set to reach US$ 1488 million by 2033 from US$ 993.51 million in 2025 at a compound annual growth rate (CAGR) of 4.2% during the forecast period from 2025 to 2033. Microplate technologies has been increasingly applied across variety of applications within the field of biotechnology research over the past couple of decades.
The primary factors driving the growth of the global fertility and pregnancy test kits market are the growing demand for self-contained solutions that the consumers can directly use, growing risk of infertility, and easy availability of time saving and cost-effective pregnancy detection solutions. In addition, increasing use of rapid testing kits in fertility clinics and home care, growing rate of adolescent pregnancies and high promotions of such solutions are some of the other factors supporting the market growth.
The global in-vitro diagnostics quality control market was valued at US$ 987.2 Mn in 2020 and expected to grow at compound annual growth rate (CAGR) of 3.9% during the forecast period from 2021 to 2029. In-vitro diagnostics quality control are tests to validate the efficacy and reliability of the in-vitro diagnostic systems and ensure its accuracy and evaluate the impact of environmental conditions and other things that can affect the test results. Erroneous in-vitro diagnostic testing systems have significant side-effects on the patients.
Cardiac markers are the substances that are released into the blood stream during heart damage. These markers are detected with specialized immunoassays and are used for diagnosis, evaluation and monitoring of patients with suspected acute coronary syndrome. These markers are very useful when patients do not present ischemic chest pain and have non-diagnostic ECG. The common cardiac markers used for evaluation of acute coronary syndrome are troponin I & T, CK-MB and myoglobins. Other biomarkers studied in this report are less specific in nature, but are also used for further evaluation, in terms of damage to the system.
The diagnostic testing for STD’s market is set to reach US$ 53,630.9 Mn by 2029 from US$ 24,981.3 Mn in 2020 performing steadily at a compounded annual growth rate (CAGR) of 8.9% during the forecast period from 2021 to 2029. As per the latest research citing of World Health Organization (WHO) more than I million people get infected with sexually transmitted disease throughout the world every day.
The global electrophoresis equipment and supplies market accounted for a value of US$ 1,957.4 Mn in 2020 and expected to attain US$ 2,891.5 Mn by 2029. Factors characterizing the market growth are worldwide rising prevalence of cancer, genetic disorders, and infectious diseases, increasing research activities coupled with funding in the proteomics and genomics fields, surging number of industry-academic research institutes collaborations, and growing focus on next-generation sequencing (NGS) research activities. Furthermore, changing regulatory requirements in the healthcare sector and mounting need to curb healthcare expenditure across the world are likely to nurture the market growth.
The diagnostics market includes instruments, reagents, test kits, software and related services used to detect diseases, assess patient health and support treatment decisions. Major areas include clinical chemistry, molecular diagnostics, immunodiagnostics, hematology, microbiology, genetic testing, companion diagnostics and point-of-care testing. Hospitals, diagnostic laboratories, research institutions, physician offices and home-care users represent the market’s major customers.
The global clinical diagnostics market is projected to increase from USD 87.99 billion in 2025 to USD 150.30 billion by 2035, registering a CAGR of 5.50% from 2026 to 2035. This forecast represents clinical diagnostics; individual segments such as molecular, digital and point-of-care diagnostics may record different growth rates.
The increasing prevalence of cancer, diabetes, cardiovascular disorders and infectious diseases is a major market growth driver. Aging populations and rising awareness of preventive healthcare are increasing the demand for routine testing and early disease detection. Healthcare providers are also using diagnostic tests to monitor treatment response, determine disease risk and select suitable therapies.
Molecular diagnostics is an important growth area because it can identify genetic material, pathogens and disease-related biomarkers with high accuracy. Polymerase chain reaction, next-generation sequencing and other molecular testing technologies are increasingly used in oncology, infectious disease testing and inherited disorder screening. Companion diagnostics are also gaining importance because they help identify patients who are likely to benefit from specific targeted medicines.
Point-of-care and home-based testing represent another major trend. Portable diagnostic systems provide results close to the patient, reducing the time between sample collection and treatment decisions. Demand is growing for rapid tests, connected glucose monitors and other decentralized testing solutions. However, laboratory-based systems remain important for complex tests, high sample volumes and confirmatory analysis.
Artificial intelligence, laboratory automation and digital connectivity are changing diagnostic workflows. Automated sample handling can improve laboratory productivity and reduce manual errors. AI-supported platforms help professionals analyze test results and identify patterns, while connected diagnostic systems enable data transfer between laboratories, hospitals and electronic health records.
Market restraints include high equipment costs, strict approval requirements, reimbursement limitations and shortages of trained laboratory professionals. Differences in test quality and healthcare access may also limit adoption in developing markets. Diagnostic companies must address data security, result accuracy and system compatibility when introducing digital platforms.
North America leads the market due to developed laboratory infrastructure, high testing volumes and early adoption of advanced technologies. Europe maintains strong demand supported by established healthcare systems. Asia-Pacific is expected to offer significant growth opportunities through 2035 due to increasing healthcare expenditure, expanding diagnostic networks and rising disease screening in China, India and Southeast Asia.
Acute Market Reports provides diagnostics market research covering market size, product and technology analysis, disease applications, end users, competitive developments, regional opportunities and forecasts through 2035. These reports support diagnostic companies, laboratories, healthcare providers and investors in making informed business decisions.